WINT — Windtree Therapeutics, Inc.

WINTWindtree Therapeutics, Inc.

NAS · US · Healthcare · Biotechnology · windtreetx.com

0.0136USD+10.12%Mkt Cap: 458439 USDP/E: 0.00Last update: 2026-06-01

Windtree Therapeutics, Inc., a biotechnology company, focuses on the development of therapeutics for the treatment of acute cardiovascular diseases. Its lead product candidate is istaroxime, which is in Phase 2b clinical…

Industry Peers

Biotechnology

VRTX

Vertex Pharmaceuticals Incorporated

Regeneron Pharmaceuticals, Inc.

Alnylam Pharmaceuticals, Inc.

40.10BUSDP/E 75.3

RVMD

Revolution Medicines, Inc.

Indicators:|

Key Statistics

Company

Market Cap458.44K USD

Enterprise Value3.76M USD

Revenue (TTM)—

Gross Profit—

Net Income (TTM)-1.79M USD

Revenue/Share—

Last Price0.0136 USD

Fiscal Year EndDec 2024

MR QuarterSep 2025

Employees14

CountryUS

SectorHealthcare

IndustryBiotechnology

ISIN—

Valuation

P/E (Trailing)0.00

P/E (Forward)-0.01

PEG—

EV/EBITDA-0.24

EV/Revenue—

P/S—

P/B-0.04

EPS (TTM)323.08

EPS (Forward)-2.13

52W Range

0.01000% of range1.860

52W High1.860 USD

52W Low0.0100 USD

Profitability

Gross Margin0.00%

Oper. Margin0.00%

EBITDA Margin0.00%

Profit Margin0.00%

ROE-17.88%

ROA-6.41%

Growth

Revenue Growth—

Earnings Growth—

Cash Flow & Leverage

Operating CF-15.40M USD

CapEx (TTM)12.00K USD

FCF Margin—

FCF Yield-5157.31%

Net Debt3.28M USD

Net Debt/EBITDA-0.21

Balance Sheet

Debt/Equity0.18

Current Ratio0.33

Quick Ratio0.01

Book Value/Sh-0.3450 USD

Cash/Share0.0060 USD

Dividends

Fwd Div Rate—

Trail. Div Rate0.0000 USD

Div. Yield—

5Y Avg Yield—

Payout Ratio0.00%

Ex-Div Date—

Pay DateApr 29, 2020

Splits

Last Split1:50

Split DateFeb 21, 2025

Analyst Consensus

Rating—

Target (Mean)—

Target Range—

# Analysts—

Ownership

Shares Out.33.71M

Float33.71M

Insiders0.00%

Institutions0.02%

Short Interest

Short Ratio0.1d

Short % Float6.25%

Short % Out.6.25%

Shares Short1.79M

Short (prev mo.)561.82K

Technical

SMA 500.0162 (-16.0%)

SMA 2000.0575 (-76.3%)

Beta1.76

S&P 52W Chg27.70%

Avg Vol (30d)196.79K

Avg Vol (10d)160.58K

Technical Indicators

RSI (14)38.7

MACD-0.0013

MACD Signal-0.0000

MACD Hist.-0.0012

BB Upper0.0273 USD

BB Middle0.0189 USD

BB Lower0.0105 USD

BB Width88.77%

ATR (14)0.0052 USD

Vol Ratio (20d)0.25x